ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Treatment of Chronic Antibody-Mediated Rejection after Kidney Transplantation: Does Rituximab and Intravenous Globulins Improve Graft Survival?

    L. Ghouti-Terki, B. Sautenet, C. Barbet, J. Halimi, Y. Lebranchu, C. Magdelaine, C. Baron, M. Büchler, P. Gatault

    Service de Néphrologie et Immunologie Clinique, CHRU, Tours, France; EA4245 Cellules Dendritiques et Greffes, Université François Rabelais, Tours, France; Laboratoire Histocompatibilité, EFS France Atlantique, Tours, France

    Background . Chronic antibody-mediated rejection (CAMR) is a major cause of renal graft loss and there is no evidence-based treatment. Patients and methods . All…
  • 2013 American Transplant Congress

    Interactions of B and T Regulatory Cells in Normal Volunteers and in Tolerant HLA-Identical Kidney Transplant Recipients

    J. Mathew, J. Leventhal, X. Huang, L. Chen, A. Tambur, J. Friedewald, M. Abecassis, J. Miller

    Surgery; Comprehensive Transplant Center, Northwestern University, Chicago, IL

    Purpose: In an HLA Identical (id) renal transplant (RT) tolerance trial using donor hematopoietic stem cells, alemtuzumab induction, and temporary maintenance immunosuppression (IS), primarily with…
  • 2013 American Transplant Congress

    Bacteremic Sepsis in Transplantation: Can Antibiotic Duration Be Shortened by the Use of Sequential Procalcitonin and Endotoxin? A Prospective Cohort Study

    D. Florescu, T. VanSchooneveld, G. Haynatzki, L. Shafer, H. Chambers, L. Hill, A. Kalil

    University of Nebraska Medical Center, Omaha, NE

    Introduction: Solid organ transplant patients with bacteremic sepsis are usually treated with antibiotics for 10-21 days. The evidence to support this length of therapy is…
  • 2013 American Transplant Congress

    Technical Variant Liver Transplantation or Whole Liver Transplantation for Pediatric Patients? A Meta-Analysis

    Z. Guo, W. Ju, Y. Wang, X. He

    Organ Transplant Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Background: Pediatric liver transplantation has become the standard treatment for children suffering from end-stage liver disease. To overcome the shortage of appropriate-sized whole liver for…
  • 2013 American Transplant Congress

    Multicenter Randomized Clinical Investigation for the Safety and Efficacy of Advagraf® (Extended-Release Tacrolimus) vs. Prograf® (Twice-Daily Tacrolimus) in De Novo Korean Adult Kidney Recipients

    C. Oh, K. Huh, J. Lee, J. Lee, H. Cho, Y. Kim

    Department of Surgery, Ajou University School of Medicine, Suwon, Kyonggi Province, Korea; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; Department of Nephrology, University of Ulsan, Ulsan, Korea; Department of Surgery, University of Ulsan, Ulsan, Korea

    Introduction: Successful outcome in renal transplantation definitely depends on patient’s compliance with immunosuppressive medications. Compliance with complex immunosuppressive drugs might be improved with regimen that…
  • 2013 American Transplant Congress

    Long-Term Graft Survival Retrieved from Donors after Cardiac Death Have Been Significantly Improved in These Two Decades Although the Procurement Technique Remains Unchanged during the Three Decades

    M. Kusaka, Y. Kubota, N. Fukami, M. Takenaka, H. Sasaki, R. Shiroki, T. Kenmochi, K. Hoshinaga

    Department of Urology, Fujita-Health University, Toyoake, Aichi, Japan; Department of Organ Transplant Surgery, Fujita-Health University, Toyoake, Aichi, Japan

    Introduction: Since 1979, 535 kidneys were retrieved from 270 DCD donors at our center, using in situ regional cooling technique. In this study, the posttransplant…
  • 2013 American Transplant Congress

    Antithymocytes Globulines and Immune Senescence in Renal Transplant Patients

    J. Bamoulid, C. Roubiou, T. Crépin, B. Gaugler, P. Tiberghien, C. Ferrand, J. Chalopin, P. Saas, D. Ducloux

    Nephrology, CHU Besançon, Besançon, France; UMR 1098, INSERM, Besançon, France; Plateforme de Biomonitoring CIC-BT506, EFS Bourgogne Franche-Comté, Besançon, France

    Background: CD4 T cell reconstitution after antithymocytes globulins (ATG) is dependent on pre-transplant thymic function and persistent ATG-induced CD4 T cell lymphopenia is associated with…
  • 2013 American Transplant Congress

    Recurrence of Focal Segmental Glomerulosclerosis after Renal Transplantation: Who Benefits from Preemptive Plasmapheresis?

    D. Bruley, L. Croze, B. Burroni, N. Pinel, P. Malvezzi, P. Zaoui

    Clinique de Néphrologie et de Transplantation Rénale, Centre Hospitalier Universitaire Michallon, Grenoble, France; Laboratoire d'Anatomie Pathologique, Centre Hospitalier Universitaire Michallon, Grenoble, France

    BACKGROUND: Post-transplant recurrence of primary focal segmental glomerulosclerosis (FSGS) has been attributed to a persistent circulating permeability factor. Prophylactic peri-operative plasmapheresis (PP) has been used…
  • 2013 American Transplant Congress

    Advagraf Immunosuppression Initiation in Kidney and Liver Transplant Recipients: 3 Month-Interim Analysis of a French Multicenter Observational Study

    D. Cantarovich, O. Cointault, A. Loupy, B. Roche, L. Rostaing, N. Kamar, E. Cassuto, M. Kessler, S. Dharancy, G. Pageaux

    from the OSIRIS Study Group, France

    Introduction: Once daily formulation of tacrolimus (TAC-OD) has been proven to be comparable to twice daily formulation (TAC-BID) in terms of efficacy and safety for…
  • 2013 American Transplant Congress

    Thymic Evidence of Clone Deletion in the Mixed Chimerism Mediated Allograft Tolerance

    W. Zhang, Y. Wang, Y. Yang, V. Gorantla, M. Solari, X. Zheng

    Plastic Surgery, Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; East Hospital of Tongji University, Shanghai, China

    Introduction: We have achieved stable mixed chimerism (MC) and tolerance in mice hind-limb transplant model using a non-myeloabative conditioning regimen, and demonstrated that the deletion…
  • « Previous Page
  • 1
  • …
  • 167
  • 168
  • 169
  • 170
  • 171
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences